Archive for November, 2011

Topical botulinum toxin has been heavily investigated over the past several years. RT001 is an investigational topical botulinum toxin type A (BoNTA) formulated with a novel peptide delivery system that enables transcutaneous transfer of the botulinum toxin.[1] Results of a Read More…

A United States FDA advisory panel began a two-day meeting this week on silicone breast implants to consider ways to improve the effectiveness of the implants’ post-approval safety studies. After being banned for 14 years, the FDA in 2006 re-approved Read More…

The FDA’s General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee conducted a hearing on August 30-31 in Gaithersburg, Md., to evaluate the progress of long-term post approval studies mandated when silicone gel-filled breast implants were approved Read More…